Cargando…
Allopurinol use and the risk of dementia: A meta-analysis of case–control studies
This study aimed to compare the risk of dementia between exposed to allopurinol and not exposed to allopurinol in persons who had gout and/or hyperuricemia. METHODS. The meta-analysis was conducted to select case–control research written in English through the help of PubMed and Web of Science. The...
Autores principales: | Lai, Shih-Wei, Hwang, Bing-Fang, Kuo, Yu-Hung, Liu, Chiu-Shong, Liao, Kuan-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239647/ https://www.ncbi.nlm.nih.gov/pubmed/35777042 http://dx.doi.org/10.1097/MD.0000000000029827 |
Ejemplares similares
-
A meta-analysis of allopurinol therapy and the risk of prostate cancer
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Allopurinol Use and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of
Cohort Studies
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022) -
A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2021) -
Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
por: Lai, Shih-Wei, et al.
Publicado: (2023)